Isolation and characterization of N98-1272 A, B and C, selective acetylcholinesterase inhibitors from metabolites of an actinomycete strain

References

• Warner J, Butler R, Arya P. Dementia. Clin Evid 2004; 12: 1361–1390
   Google Scholar
• Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, White CL, Parhad IM, Price DL. Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease. Psychopharmacol Bull 1983; 19: 437–440
   PubMedGoogle Scholar
• Roberts F, Lazareno S. Cholinergic treatments for Alzheimer's disease. Biochem Soc Trans 1989; 17: 76–79
   PubMed Web of Science ®Google Scholar
• William ER. Current pharmacologic options for patients with Alzheimer's disease. Ann Gen Hosp Psych 2003; 2: 1–12
   PubMedGoogle Scholar
• Jiang Y, Li WJ, Cui XL, Zhang H, Xu LH, Jiang CL. Polyphasic classification of Streptomyces bannaenesis sp.nov. J Yunnan Uni 2004; 26: 179–182
   Google Scholar
• Ellman GL, Courtney KD, Andres V, Featherstone RM. In vitro effects of various cholinesterase inhibitors on acetyl-and butyrylcholinesterase of healthy volunteers. Biochem Pharmacol 1961; 7: 88–95
   PubMed Web of Science ®Google Scholar
• Zeeck A, Schroder K, Frobel K, Grote R, Thuerucke R. The Structure of Manumycin. I. Characterization. J Antibiot 1987; 40: 1530–1540
   Web of Science ®Google Scholar
• Zeeck A, Frobel K, Heusel C, Schroder K, Thiericke R. The Structure of Manumycin. II. Derivatives. J Antibiot 1987; 40: 1541–1548
   Google Scholar
• Shu YZ, Huang S, Wang RR, Lam KS, Klohr SE, Volk KJ, Pirnik DM, Wells JS, Fernandes PB, Patel PS, Manumycins E. F and G, new members of Manumycin class antibiotics, from Streptomyces sp. J Antibiot 1994; 47: 324–333
   Google Scholar
• Nayashi K, Nakagawa M, Fujita T, Tanimori S, Nakayama M. Nisamycin, a new Manumycin group antibiotic from Streptomyces sp. K106. J Antibiot 1993; 46: 1904–1907
   PubMed Web of Science ®Google Scholar
• Franco CM, Maurya R, Vijayakumar EK, Chatterjee S, Blumbach J, Ganguli BN. Alisamycin, a new antibiotic of the Manumycin group. I. Taxonomy, production, isolation and biological activity. J Antibiot 1991; 44: 1289–1293
   Google Scholar
• Kohno J, Nishio M, Kawano K, Nakanishi N, Suzuki S, Uchida T, Komatsubara S. TMC-1 A B C and D new antibiotics of the Manumycin group produced by Streptomyces sp. Taxonomy, production, isolation, physico-chemical properties, structure elucidation and biological properties. J Antibiot 1996; 49: 1212–1220
   Google Scholar
• Hara M, Akasaka K, Akinaga S, Okabe M, Nakano H, Gomez R, Wood D, Uh M, Tamanoi F. Identifiction of Ras farnesyltransferase inhibitors by microbioal screening. Proc Natl Acad Sci USA 1993; 90: 2281–2285
   PubMed Web of Science ®Google Scholar
• Tanaka T, Tsukuda E, Uosaki Y, Matsuda Y. EI-1511-3-5 and EI-1625-2. Novel Interleukin-1β converting enzyme inhibitions produced by Streptomyces sp. E-1511 and E-1625, III. Biochemical properties of E-1511 and E-1625. J Antibiot 1996; 49: 1085–1090
   Google Scholar
• Yeung SC, Xu G, Pan J, Christgen M, Bamiagis A. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells. Cancer Res 2000; 60: 650–656
   PubMed Web of Science ®Google Scholar
• Ibach B, Haen E. Acetylcholinesterase inhibition in Alzheimer's disease. Curr Pharm Des. 2004; 10: 231–251
   PubMed Web of Science ®Google Scholar
• Pacheco G, Palacios-esquivel R, Moss DE. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: Selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase. J Pharmacol Exp Ther 1995; 274: 767–770
   PubMed Web of Science ®Google Scholar
• Thomsen T, Zendeh B, Fischer JP, Kewitz H. In vitro effects of various cholinesterase inhibitors on acetyl-and butyrylcholinesterase of healthy volunteers. Biochem Pharmacol 1991; 41: 139–141
   PubMed Web of Science ®Google Scholar
• Pang YP, Quiram P, Jelacic T, Hong F, Brimijoin S. Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease. J Biol Chem 1996; 271: 23646–23649
   Google Scholar
• Raves ML, Harel M, Pang YP, Silman I, Kozikowski AP, Sussman JL. Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A. Nat Struct Biol 1997; 4: 57–63
   PubMedGoogle Scholar
• Kuno F, Otoguro K, Shiomi K, Iwai Y, Omura S. Arisugacins A and B, novel and seletive acetylcholinesterase inhibitors from Penicillium sp. FO-4259, I. Screening, taxonomy, fermentation, isolation and biological activity. J Antibiot 1996; 49: 742–747
   PubMed Web of Science ®Google Scholar
• Cho KM, Kim WG, Lee CK, Yoo ID. Terreulactones A, B, C, and D: Novel acetylcholinesterase inhibitors produced by Aspergillus terreus. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot 2003; 56: 344–350
   PubMed Web of Science ®Google Scholar
• Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goelder M, et al. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci USA 1993; 90: 9031–9035
   PubMed Web of Science ®Google Scholar
• Johnson JL, Cusack B, Hughes TF, McCullough EH, Fauq A, Romanovskis P, Spatola AF, Rosenberry TL. Inhibitors tethered near the acetylcholinesterase acitive site serve as molecular rulers of the peripheral and acylation sites. J Biol Chem 2003; 278: 38948–38955
   PubMed Web of Science ®Google Scholar
• Bar-On P, Millard CB, Harel M, Dvir H, Enz A, Sussman JL, Silman I. Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine. Biochemistry 2002; 41: 3555–3564
   PubMed Web of Science ®Google Scholar
• Haviv H, Wong DM, Greenblatt HM, Carlier PR, Pang YP, Silman I, Sussman JL. Crystal packing mediates enantioselective ligand recognition at the peripheral site of acetylcholinesterase. J Am Chem Soc 2005; 127: 11029–11036
   PubMed Web of Science ®Google Scholar
• Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem 2003; 278: 41141–41147
   PubMed Web of Science ®Google Scholar
• Costantini C, Weindruch R, Della Valle R, Puglielli L. A TrKA-to-p75NTR molecular switch activates amyloid β-peptide generation during aging. Biochem J 2005; 391: 59–67
   PubMed Web of Science ®Google Scholar